Bovine respiratory syncytial virus (BRSV) causes inflammation and obstruction of the small airways, leading to severe respiratory disease in young calves. The virus is closely related to human (H)RSV, a major cause of bronchiolitis and pneumonia in young children. The ability to manipulate the genome of RSV has provided opportunities for the development of stable, live attenuated RSV vaccines. The role of the SH protein in the pathogenesis of BRSV was evaluated in vitro and in vivo using a recombinant (r)BRSV in which the SH gene had been deleted. Infection of bovine epithelial cells and monocytes with rBRSVDSH, in vitro, resulted in an increase in apoptosis, and higher levels of TNF-a and IL-1b compared with cells infected with parental, wildtype (WT) rBRSV. Although replication of rBRSVDSH and WT rBRSV, in vitro, were similar, the replication of rBRSVDSH was moderately reduced in the lower, but not the upper, respiratory tract of experimentally infected calves. Despite the greater ability of rBRSVDSH to induce proinflammatory cytokines, in vitro, the pulmonary inflammatory response in rBRSVDSH-infected calves was significantly reduced compared with that in calves inoculated with WT rBRSV, 6 days previously. Virus lacking SH appeared to be as immunogenic and effective in inducing resistance to virulent virus challenge, 6 months later, as the parental rBRSV. These findings suggest that rBRSVDSH may be an ideal live attenuated virus vaccine candidate, combining safety with a high level of immunogenicity.
of that seen in babies vaccinated with formalin-inactivated HRSV (Kim et al., 1969) . The ability to manipulate the genome of RSVs has allowed analysis of the role of viral proteins in the pathogenesis of disease and has provided opportunities for the development of stable, live attenuated virus vaccines. However, a problem with this approach has been that attenuation is usually based on decreased virus replication, which is associated with reduced immunogenicity. Although an effective HRSV vaccine is not yet available, one promising candidate is a temperature-sensitive mutant virus that also lacks the SH gene, rA2cp248/404/1030/DSH. Following intranasal (i.n.) vaccination of 1-to 2-month-old infants, this virus was well tolerated and immunogenic, and protected against a second dose of the same vaccine given 4 to 8 weeks after the first dose (Karron et al., 2005) .
The SH protein, which is a short type II integral membrane glycoprotein, is not essential for virus replication in cell culture. However, HRSV lacking the SH gene (rHRSVDSH) exhibited different patterns of site-specific attenuation in the respiratory tract of mice and chimpanzees. Thus, replication of rHRSVDSH was attenuated only in the upper respiratory tract of mice (Bukreyev et al., 1997) , and only in the lower respiratory tract of chimpanzees (Whitehead et al., 1999) . Nevertheless, chimpanzees infected with rHRSVDSH developed less rhinorrhoea than those infected with WT HRSV. The reasons for differences in the site-specific attenuation of rHRSVDSH in mice and chimpanzees are not clear. Studies of rHRSVDSH in cell culture suggest that, similar to other paramyxoviruses, the SH protein inhibits apoptosis and TNF-a signalling (Fuentes et al., 2007; Lin et al., 2003) . The HRSV SH protein forms pentameric and hexameric complexes in membranes, altering membrane permeability, and the transmembrane domain of SH has been shown to act as an ion channel in synthetic membranes (Carter et al., 2010; Gan et al., 2012; Perez et al., 1997) . Transmembrane pore-forming viral proteins that form ion channels (viroporins), such as influenza virus M2 and encephalomyocarditis virus 2B, play a central role in activation of the NLRP3 inflammasome pathway resulting in secretion of IL-1b and IL-18 (Ichinohe et al., 2010; Ito et al., 2012) . There is evidence that HRSV also activates the NLRP3 inflammasome, inducing secretion of IL-1b (Segovia et al., 2012; Triantafilou et al., 2013) .
IL-1b and IL-18 play an important role in inflammation by orchestrating the pro-inflammatory response, and are important regulators of innate and adaptive immune responses. These cytokines are produced as cytosolic precursors that require proteolytic cleavage induced by the inflammasome for activation and secretion. BRSV and HRSV induce the production of pro-inflammatory cytokines, including IL-b, in vivo and in vitro (BermejoMartin et al., 2007; Fach et al., 2010; Werling et al., 2002) . Activation of the NLRP3/ASC inflammasome by HRSV in mouse bone marrow macrophages is initiated by Toll-like receptor-2 (TLR-2)/Myd88/NF-kB signalling (signal 1), and reactive oxygen species (ROS) and K + ion efflux (signal 2) (Segovia et al., 2012) . In contrast, studies in human lung epithelial cells indicated that activation of the NLRP3/ASC inflammasome by HRSV was initiated by TLR-4 (signal 1) and involved the SH protein of RSV (signal 2) (Triantafilou et al., 2013) . Thus, rHRSVDSH failed to induce IL-1b secretion from primary human epithelial lung cells.
Activation of the inflammasome and production of IL-1b is responsible for neutrophil recruitment and inflammation in the lungs of mice infected with influenza virus (Ichinohe et al., 2009; Schmitz et al., 2005; Thomas et al., 2009) . The demonstration that rHRSVDSH failed to induce IL-1b secretion in airway epithelial cells (Triantafilou et al., 2013) may explain, at least in part, the reduced rhinorrhoea seen in chimpanzees infected with rHRSVDSH (Whitehead et al., 1999) . However, activation of the inflammasome plays an important role in orchestrating the innate and adaptive immune response, and mice deficient in components of the inflammasome pathway or which lack IL-18 receptors are more susceptible to influenza virus infection than wildtype mice and have reduced T-cell and antibody responses (Ichinohe et al., 2009; Schmitz et al., 2005) . These observations suggest that failure to induce IL-1b by rHRSVDSH may have a negative impact on priming of a protective immune response, and consequently, deletion of SH would be expected to enhance virus replication in the respiratory tract, rather than attenuate replication as has been observed in mice and chimpanzees.
In order to understand the role of the SH protein in induction of IL-1b and the pathogenesis of RSV, we analysed the effects of deletion of the SH gene on the induction of pro-inflammatory cytokines and apoptosis in vitro and on the pathogenesis of BRSV in calves, a natural host of the virus. In addition, the ability of mucosal immunization with rBRSVDSH to induce a protective immune response was evaluated.
RESULTS

Induction of apoptosis by rBRSV lacking the SH gene
Compared with parental rHRSV, rHRSV lacking SH produces larger plaques and grows to slightly higher titres in some, but not other cell lines (Bukreyev et al., 1997) , and induces significantly more apoptosis than parental rHRSV in L929 and A549 cells (Fuentes et al., 2007) . Although we found that there was little or no difference either in the plaque size of parental, WT rBRSV and rBRSVDSH in Vero cells (data not shown), or in the replication of rBRSVDSH and WT rBRSV in either primary calf testes or MDBK cells (Fig. 1) , a cytopathic effect was seen earlier in MDBK cells infected with rBRSVDSH than in cells infected with WT rBRSV. Infection of MDBK cells or bovine monocytes (CD14 + cells) with rBRSVDSH induced significantly more apoptosis than WT rBRSV, 48 h or 24 h after infection, respectively (P,0.0001, P,0.01) (Fig. 2a, b) . Apoptosis of bovine monocytes 24 h after infection was only seen at an m.o.i. of 3 and there was little or no apoptosis at an m.o.i. of 1 (Fig. 2b) .
Induction of pro-inflammatory cytokines
Previous studies have shown that the SH protein of paramyxoviruses plays an important role in inhibiting induction of TNF-a (Fuentes et al., 2007; Lin et al., 2003) . We therefore analysed the effect of infection with rBRSVDSH on the level of TNF-a in the supernatant from bovine monocytes. Although neither WT virus nor rBRSVDSH replicated in bovine monocytes, cells infected with rBRSVDSH produced significantly greater amounts of TNF-a than those infected with the parental WT rBRSV (Fig. 3a) . Similarly, the level of IL-1b in supernatants from bovine monocytes and MDBK cells infected with rBRSVDSH was significantly greater than that from cells infected with WT rBRSV (Fig. 3b, c) .
The SH-deleted mutant of BRSV is attenuated in the lower respiratory tract of calves Since previous studies have shown that there are differences in the site-specific attenuation of rHRSVDSH in mice and chimpanzees, we compared the replication of WT rBRSV and rBRSVDSH in the respiratory tract of gnotobiotic calves following i.n. and intratracheal (i.t.) inoculation. Replication of WT and DSH rBRSV in the nasopharynx of calves was not significantly different, at least up to 6 days post-infection (p.i.) (Fig. 4a) . In contrast, replication of rBRSVDSH in the lower respiratory tract was attenuated compared with that of WT rBRSV (Fig. 4b) . Thus, levels of virus were significantly (P,0.01) higher in lung homogenates from calves infected with the WT virus than from those infected with the DSH mutant, for samples taken from all lobes. Furthermore, the titre of rBRSVDSH in bronchiolar lavage (BAL) cells was 10-fold less than that of WT rBRSV, although the difference was not statistically significant.
None of the calves developed clinical signs of respiratory disease. However, in contrast to calves infected with WT rBRSV, calves infected with rBRSVDSH developed little or no macroscopic pneumonia (Fig. 5a) . Furthermore, the total number of cells in BAL from calves infected with rBRSVDSH was twofold less than that from calves infected with WT rBRSV, and the numbers of neutrophils in BAL were significantly reduced (Fig. 5b) . Microscopic lung lesions in calves infected with WT rBRSV were similar to those described previously (Thomas et al., 1984) and were characterized by a proliferative and exudative bronchiolitis, a peribronchiolar accumulation of lymphocytes and alveolitis.
Microscopic lung lesions in calves infected with rBRSVDSH were similar but much less extensive. Numerous apoptotic cells can be seen in vacuoles in bronchial epithelial cells of BRSV-infected calves (Viuff et al., 2002) . Since rBRSVDSH infection increased apoptosis, in vitro, we analysed sections of trachea and lung from calves infected with WT or DSH rBRS viruses for vacuoles containing cell debris. Such vacuoles were observed in bronchial and tracheal epithelial cells from calves infected with either WT rBRSV or rBRSVDSH, but not in airway epithelium from mockinfected calves (Fig. 6 ). Although microscopic changes were not very extensive in calves infected with rBRSDSH, there did not appear to be any major differences in the numbers of vacuoles containing cell debris in areas of lung sections As controls, cells were exposed to mock-infected tissue culture cell lysate (Con). At 24 h post-infection, levels of TNF-a (a) and c) in the supernatant were determined by ELISA. Results are expressed as the mean±SD of triplicate samples. *, WT rBRSV induced significantly higher levels of TNF-a or IL-1b than controls, P,0.03; **, rBRSVDSH induced significantly higher levels of TNF-a or IL-1b than WT rBRSV, P,0.0001. showing inflammation when compared with sections from calves infected with WT rBRSV.
Mucosal immunization with rBRSV lacking SH protects against challenge with virulent BRSV
In order to determine the ability of mucosal immunization with rBRSVDSH to induce a protective immune response, groups of four or five colostrum-restricted calves that had been inoculated i.n. and i.t. with WT rBRSV, rBRSVDSH or control Vero cell lysate, 6 months previously, were challenged with the Snook strain of BRSV. As seen previously in gnotobiotic calves, there was no difference in the replication of WT and DSH rBRS viruses in the nasopharynx, and virus was cleared by day 8 in both groups of infected animals. Furthermore, none of the calves developed clinical signs of respiratory disease. Although calves infected with WT rBRSV had higher levels of maternally derived BRSVspecific serum antibodies at the time of mucosal immunization than calves infected with rBRSVDSH, the serum IgG antibody response, as determined by ELISA, and the neutralizing antibody response induced by rBRSV and rBRSVDSH were not statistically significantly different (Fig. 7a, c) . Infection with WT or DSH rBRSV also induced BRSV-specific IgA in nasal secretions. Mucosal IgA reached a peak at 2 weeks after vaccination in both groups of calves and the titres were not significantly different (Fig. 7b) . After a peak between 4 and 8 weeks after immunization, levels of BRSV-specific serum IgG and neutralizing antibodies declined slowly over the 6 months. In contrast, mockinfected control calves did not develop a BRSV-specific serum or mucosal antibody response (results not shown).
Following challenge with virulent BRSV, clinical signs of respiratory disease were seen 5 to 6 days after challenge in two out of four control calves, one out of four calves immunized with rBRSVDSH and none of the calves immunized with WT rBRSV. At post-mortem examination, 6 days after BRSV challenge, macroscopic lung lesions of .5 % of the lung were observed in three out of four control calves (Fig. 8a) . In contrast, there was little or no pneumonic consolidation in calves immunized with either WT rBRSV or rBRSVDSH (Fig. 8a) . Following challenge, virus was not isolated from the nasopharynx or lung tissue of any of the immunized calves but was isolated from the nasopharynx (Fig. 8b ) and lung tissue of three of the four control calves (results not shown). Similarly, virus was not isolated, or only detected in low titres, in BAL cells from calves immunized with rBRSVDSH or WT rBRSV, but was isolated in high titres from control calves (Fig. 8b) . 
DISCUSSION
In this study, we demonstrated that although BRSV lacking the SH gene replicated as efficiently as WT rBRSV in tissue culture cells, the mutant virus exhibited sitespecific attenuation in the bovine respiratory tract, and was as effective as WT rBRSV in inducing resistance to challenge with virulent BRSV, 6 months after vaccination. Although previous studies have shown that the final titre of rBRSVDSH in MDBK cells was slightly reduced when compared with that of parental rBRSV (Karger et al., 2001 ), we could not detect any differences in the replication of rBRSVDSH and parental WT rBRSV in either calf testes or MDBK cells. Studies with rHRSV lacking the SH gene (D46/ 6368) showed that the mutant virus formed larger plaques on Hep-2 cells, and replicated to higher titres than parental rHRSV in some, but not all, cell lines tested (Bukreyev et al., 1997) . Therefore, differences in the replication of rBRSVDSH, in vitro, may be related to the use of different cell lines, or to differences in cell lines maintained in different laboratories. Taken together, studies on rHRSV and rBRSV lacking the SH protein demonstrate that SH is not essential for virus replication, in vitro. In contrast, the replication of rBRSVDSH was attenuated in the lungs of calves. Thus, the site-specific attenuation of rBRSVDSH in calves resembled that of rHRSVDSH in chimpanzees (Whitehead et al., 1999) .
Although the parental WT rBRSV did not induce clinical signs of disease, it induced an extensive pulmonary inflammatory response and gross pneumonic lesions. Attempts to induce clinical signs of respiratory disease in calves experimentally infected with BRSV have yielded inconsistent results. However, non-or low-cell-culture-passaged virus can induce disease similar to that seen in naturally occurring outbreaks (van der Poel et al., 1996) . In the field, other factors such as secondary infections, adverse environmental temperatures or housing may contribute to the severity of disease. Nevertheless, the marked reduction in lung pathology seen in calves infected with rBRSVDSH compared with that induced by WT rBRSV suggests that SH plays a role in RSV pathogenesis.
HRSV and BRSV do not usually induce apoptosis until the late stages of infection (Cristina et al., 2001; Kotelkin et al., 2003) . However, rBRSVDSH resembled rHRSVDSH in inducing significantly more apoptosis than WT virus, in vitro (Fuentes et al., 2007) . Studies with rPIV5DSH have suggested that the SH protein inhibits TNF-a-induced apoptosis (Lin et al., 2003) . Like rPIV5DSH, we found that rBRSVDSH-infected bovine monocytes produced significantly greater amounts of TNF-a than cells infected with WT rBRSV. Therefore, the greater level of apoptosis seen in rBRSVDSH-infected cells compared with cells infected with WT rBRSV may be mediated by the higher levels of TNF-a induced in rBRSVDSH-infected cells. However, apoptosis of bovine monocytes, 24 h after infection with rBRSVDSH at an m.o.i. of 1, was low at a time when high levels of TNF-a were present in the supernatant.
Apoptosis is an important early host defence that limits virus replication and spread, and many viruses have developed strategies to inhibit apoptosis, thereby prolonging their ability to replicate. An early onset of apoptosis following virus infection may help to control virus replication, as seen for rPIV5DSH, which induced increased apoptosis, in vitro, and was attenuated in vivo (He et al., 2001) . The observation that a large number of apoptotic cells containing BRSV antigen can be seen in vacuoles in the bronchial epithelium of calves infected 6 days previously with BRSV has led to the suggestion that apoptosis is an important pathway of virus clearance in BRSV-infected calves (Viuff et al., 2002) . Therefore, an accelerated or increased induction of apoptosis by rBRSVDSH may explain its restricted replication in the lungs. However, this does not explain the similar level of replication and rate of clearance of rBRSVDSH and WT rBRSV seen in the nasopharynx. It is possible that the higher pro-apoptotic potential of rBRSVDSH could predispose the airways to secondary bacterial infections. However, we found no evidence for this, and, furthermore, we could not detect any major differences in the number of vacuoles containing cell debris in ciliated airway epithelium in calves infected 6 days previously with rBRSVDSH or WT rBRSV. An alternative explanation for the site-specific attenuation of rBRSVDSH may be related to induction of TNF-a by monocytes and macrophages, which are more prevalent in the lower respiratory tract than in the nasopharynx. Although TNF-a is a major mediator of RSV-associated illness in BALB/c mice, it is important in clearance of virusinfected cells during the early stages of infection (Rutigliano & Graham, 2004) .
The observation that rBRSVDSH induced significantly higher levels of IL-1b than WT rBRSV in MDBK cells and bovine monocytes contrasts with that of Triantafilou et al. (2013) , who found that rHRSVDSH did not induce secretion of IL-1b in primary human lung epithelial cells. The reasons for this discrepancy are not clear. One possibility is that, since there is only 38 % amino acid identity between the SH proteins of BRSV and HRSV, they may have different functions. However, the close relationship between HRSV and BRSV makes this unlikely. The predicted hydropathy profiles of BRSV and HRSV SH proteins are similar (Samal & Zamora, 1991) and, of the amino acids (His22, and either His51 or Trp15) that have been implicated in HRSV SH ion channel activity (Carter et al., 2010; Gan et al., 2012) , Trp15 and His51 are conserved in the BRSV SH protein. Since activation of the inflammasome by HRSV is mediated by different signals in different cells (Segovia et al., 2012; Triantafilou et al., 2013) , it is possible that differences in induction of IL-1b by rHRSVDSH and rBRSVDSH may be related to the type of cells that were infected. However, rBRSVDSH induced higher levels of IL-1b than WT rBRSV in both bovine epithelial (MDBK) cells and bovine monocytes. Alternatively, differences in the response to infection with DSH RS viruses may be related to differences in their construction resulting in differing levels of read-through transcripts, and consequently, the level of expression of downstream viral genes. Thus, differences in the intergenic regions, or expression of an additional gene such as GFP, as in the rHRSVDSH used in studies by Triantafilou et al. (2013) , may have affected the gradient of transcription and the level of expression of, for example, the G and F proteins. The G protein of HRSV inhibits IL-6 and IL-1b production in human monocytes . Therefore, differences in the level of G protein produced by DSH viruses may influence induction of IL-1b. There are high levels of read-through mRNAs of the M gene and the respective downstream genes in rHRSV (D46/6368) (Bukreyev et al., 1997) and rBRSVDSH (Karger et al., 2001) . However, this does not appear to translate to corresponding higher levels of downstream proteins in cells infected with rHRSV (D46/ 6368). Other studies have shown that TNF-a can induce caspase-1 activation and IL-1b secretion (Dinarello et al., 1986; Franchi et al., 2009 ). Therefore, it is possible that increased secretion of IL-1b by cells infected with rBRSVDSH was mediated by TNF-a.
Studies in mice infected with influenza virus have demonstrated that IL-1b is responsible for neutrophil recruitment and inflammation in the lungs (Ichinohe et al., 2009; Schmitz et al., 2005; Thomas et al., 2009) . Increased secretion of IL-1b by bovine monocytes infected with rBRSVDSH might be expected to result in increased inflammation in the lungs of calves infected with this virus. However, the pulmonary inflammatory response in calves infected with rBRSVDSH was reduced in comparison with that seen in calves infected with WT rBRSV 6 days previously. Early induction of IL-1b and TNF-a by rBRSVDSH in the lungs may have contributed to rapid control of virus replication and, therefore, less inflammation, 6 days after infection. Further studies to compare innate immune responses in the lungs of calves infected with rBRSVDSH or WT rBRSV are required to understand the mechanisms responsible for the reduced virus replication and reduced pulmonary inflammatory response in calves infected with rBRSVDSH.
Despite the attenuation of rBRSVDSH in the lower respiratory tract of calves, BRSV-specific antibody responses induced by the mutant virus were similar to those induced by WT rBRSV. Furthermore, infection with rBRSVDSH was as effective as that with WT rBRSV in protecting against BRSV challenge 6 months later. The observation that attenuation of rBRSVDSH did not appear to be associated with reduced immunogenicity may be related to increased activation of components of the innate immune response, such as apoptosis and IL-1b. Apoptosis enhances antigen presentation, and apoptotic cells or bodies are major sources for antigen cross-presentation. An increase in apoptosis by a recombinant rabies virus overexpressing cytochrome c resulted in attenuation of pathogenicity and enhanced immunity (Pulmanausahakul et al., 2001) . Similarly, the enhanced immune response and greater vaccine efficacy against influenza virus induced in mice by rPIV5DSH expressing influenza haemagglutinin was associated with increased apoptosis, in vitro, and attenuation of virus replication, in vivo (Li et al., 2013) . Activation of the inflammasome and induction of IL-1b and IL-18 secretion also appear to be important for induction of adaptive immunity. Thus, priming of influenza virus-specific T cells, and levels of nasal IgA were significantly reduced in mice deficient in ASC, caspase-1 or IL-1R (Ichinohe et al., 2009) ; and deletion of the gene encoding the viral IL-1b receptor in modified vaccinia virus Ankara enhanced the induction of memory CD8 T cells (Staib et al., 2005) . However, other studies have failed to demonstrate a role for caspase-1 in induction of the adaptive immune response to influenza virus (Thomas et al., 2009 ).
In conclusion, rBRSVDSH showed site-specific attenuation in the respiratory tract of calves, and was as immunogenic and effective as WT rBRSV in inducing resistance to challenge with virulent BRSV. These properties may be related to an increased induction of components of the innate immune response, such as apoptosis and IL-1b, in rBRSVDSH-infected cells. In contrast to a biologically derived vaccine candidate attenuated by point mutations, rBRSVDSH containing the deletion of an entire gene should be highly refractory to reversion to virulence. Furthermore, the probability of regaining the deleted gene by recombination is likely to be a very rare event (Spann et al., 2003) . As the fusion glycoprotein, which is the major protective antigen, is highly conserved between BRSV isolates (Valarcher et al., 2000) , immune responses induced by SH-deleted BRSV are likely to be broadly protective in the field. Therefore, rBRSVDSH appears to be an ideal vaccine candidate, combining safety with a high level of immunogenicity.
METHODS
Viruses and cells. WT recombinant (r)BRSV and virus lacking the SH gene (DSH) were derived from full-length cDNA of BRSV strain A51908, variant Atue51908 (GenBank accession no. AF092942) (Karger et al., 2001) . Stocks of rBRSV were prepared in Vero cell monolayers, infected at an m.o.i. between 0.1 and 0.5, in Dulbecco's modified Eagle's medium (DMEM; Gibco-BRL) containing 2 % heatinactivated fetal calf serum (FCS). All recombinant virus stocks were free from contamination with bovine viral diarrhea virus (BVDV) and mycoplasmas. Virulent BRSV consisted of BAL prepared from a gnotobiotic calf, inoculated 6 days previously with the Snook strain of BRSV, which is closely related to BRSV Atue51908 (Valarcher et al., 2003) . The BAL was free from other viruses, mycoplasmas and bacteria as assessed by inoculation of tissue culture cells, or mycoplasmal or bacterial media. Replication of rBRSV and rBRSVDSH in primary calf testes cells and MDBK cells, infected at an m.o.i. of 0.1 and incubated at 37 uC or 6 days, was determined as described previously (Valarcher et al., 2003) . Virus titres were determined by plaque assay on fetal calf kidney (FCK) or Vero cell monolayers in 35 mm Petri dishes (Thomas et al., 1982) .
Calves and experimental design. Gnotobiotic, BRSV-seronegative calves were derived, reared and maintained individually in plastic isolators as described previously (Dennis et al., 1976) . To evaluate the virulence of rBRSV, groups of three or four gnotobiotic calves were infected at 2 to 3 weeks of age with approximately 10 6 p.f.u. virus in a volume of 10 ml administered i.n. and 10 ml i.t. A clinical examination was performed twice a day following virus infection, and nasopharyngeal swabs were obtained daily to monitor virus excretion from the nasopharynx. Calves were killed 6 days after infection, by intravenous injection of sodium pentobarbital. At post-mortem examination, macroscopic lung lesions were recorded on a standard lung diagram, and the extent of pneumonic consolidation was expressed as a percentage of the lung area. BAL was collected by irrigating the lungs from each calf with 300 ml PBS (Taylor et al., 1995) . Cytocentrifuge preparations of BAL cells were fixed in neutral buffered formalin and stained with haematoxylin and eosin. Differential counts of 300 to 350 cells per slide were made using oil immersion. Cells prepared from 100 ml BAL by centrifugation at 1200 g for 15 min at 4 uC were resuspended in 5 ml of lung buffer for analysis of virus titre (Taylor et al., 1995) . Three pieces of pneumonic lung taken from different lobes were homogenized in lung buffer to give a 20 % (w/v) suspension. Titres of rBRSV in nasopharyngeal swabs, BAL cells and lung homogenates were determined by plaque assay on Vero cells.
The ability of rBRSVDSH to induce protective immunity was determined in three groups of colostrum-restricted calves, produced by collecting them at birth and artificially feeding them with 500 ml of colostrum that contained low levels of BRSV-specific antibodies. Calves were inoculated i.n. and i.t. at 1 to 4 weeks of age, with 5610 6 p.f.u. WT rBRSV, rBRSVDSH or a lysate of non-infected Vero cells. Nasopharyngeal swabs were obtained daily for 10 days to monitor virus excretion from the nasopharynx. Blood was obtained at intervals for analysis of BRSV-specific antibodies. Six months after vaccination, calves were challenged i.n. and i.t. with 1610 4 p.f.u. of the virulent Snook strain of BRSV in BAL fluid. Following challenge, nasopharyngeal swabs were obtained daily, and calves were killed 6 days after challenge to determine the extent of gross pneumonic lesions and the titre of virus in BAL cells.
All calf experiments were performed under the regulations of the Home Office Scientific Procedures Act (1986) of the UK. The studies have been approved by the Pirbright Institute Animal Welfare & Ethical Review Body.
Serology. BRSV-specific antibodies in sera were analysed by ELISA using a lysate of BRSV (Snook)-infected FCK cells as antigen and mock-infected FCK cells as control antigen (Taylor et al., 1995) . Neutralizing antibodies were determined by a plaque reduction assay on Vero cells using the Snook strain of BRSV and heat-inactivated (56 uC for 30 min) sera (Kennedy et al., 1988) .
Histology. A tracheal ring taken from approximately 5 cm below the larynx and pieces of lung from each of three different lobes were fixed in 10 % neutral buffered formalin and embedded in paraffin wax, and sections were stained with haematoxylin and eosin.
Induction of pro-inflammatory cytokines and apoptosis, in vitro. Bovine monocytes were prepared from heparinized venous blood by centrifugation at 1200 g over Histopaque 1086 (Sigma). The peripheral blood mononuclear cells were washed three times with PBS and CD14 + cells were purified by magnetic antibody cell sorting using anti-human CD14 + microbeads (Miltenyi Biotec) (Sopp & Howard, 1997) , following the manufacturer's instructions. CD14 + cells in RPMI medium with 3 % FCS, ampicillin (0.1 mg ml
21
) and 5610 25 M 2-mercaptoethanol and MDBK cells in Eagle's MEM containing 2 % FCS, 1 % non-essential amino acids, 100 U penicillin ml
, and 100 mg streptomycin ml 21 were infected with WT BRSV or BRSVDSH at an m.o.i. of 1 or 3. Virus was adsorbed for 1.5 h at 37 uC in 5 % CO 2 /air. After adsorption, the cells were washed twice with PBS, fresh medium was added and cells were incubated at 37 uC in 5 % CO 2 /air. As a control, cells were treated with mock-infected Vero cell lysate for 1.5 h. At 24 h post-infection, supernatants were collected and levels of IL-1b were analysed using a bovine IL-1b ELISA kit (Pierce Protein Biology Products), and levels of TNF-a were analysed by ELISA as described previously (Kwong et al., 2010) . At 24 h post-infection, bovine monocytes were removed from tissue culture wells using cell-dissociation fluid solution (Sigma-Aldrich), and MDBK cells were removed at 24 h and 48 h p.i. by treatment with trypsin and EDTA. Terminal deoxynucleotidyltransferase dUTP nick end labelling (TUNEL) was performed using the APO-BRDU kit (AbD Serotec), according to the manufacturer's instructions, to detect apoptotic cells by dual colour flow cytometry.
Statistics. Data were analysed for statistical significance using either ANOVA or a two-sample t-test. P values less than 0.05 were considered statistically significant. Viral levels in lung homogenates of calves were analysed using a linear mixed model with log 10 (p.f.u. g 21 ) as the response variable, virus (WT or DSH) and lobe (RA, RC or LC) as fixed effects and calf as a random effect. Model selection proceeded by stepwise deletion of non-significant terms (as judged by the Akaike information criterion), starting from a model including virus, lobe and an interaction between them. Once a final model had been constructed, differences between factors were explored using Tukey's honest significant differences (which corrects for multiple testing). Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206, 79-87.
